The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,275,766 in first-year total cost, median $637,883.
Most frequent study sections
- Special Emphasis Panel[ZTR1 SBIR-5 (03)]1
- Special Emphasis Panel[ZTR1 SBIR-5 (04)]1
Most frequent institutions
- CURI BIO INC1
- HESPEROS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency1U44TR004811-01A1 | HICKMAN, JAMES JKRONAUGE, JAMES F | HESPEROS, LLC, FL | $1,000,000 | ZTR1 |
| 2023 | High-Throughput NMJ Assay for Botox Potency Screening1U44TR004795-01 | GEISSE, NICHOLAS ANDREW | CURI BIO INC, WA | $275,766 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.